2026 NPPES data Dermatology Physician NPI 1154596096 M.D.
Verify on CMS →

KATHERINE MASTERPOL, M.D.

Dermatology Physician in BURLINGTON, Massachusetts. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
401
Medicare Part D claims · 215 beneficiaries · Dermatology Physician avg: 729
Generic prescribing
90%
generic claims · 10% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
75/100
▼ 8 pts below national avg 83.1 · [object Object]
Industry payments
$659.42
20 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

KATHERINE MASTERPOL, M.D. reported a CMS MIPS final score of 75/100 — below the 83.1 national average — and filed 401 Medicare Part D claims in 2023.

75/100
MIPS score · -8 vs avg
401
Part D claims, 2023
90%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

KATHERINE MASTERPOL, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

75 15th percentile higher than 15% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). This entry sits in this band. 80–90: 129,887 scored providers (27%). Above this entry. 90–100: 189,403 scored providers (40%). Above this entry. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

KATHERINE MASTERPOL, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about KATHERINE MASTERPOL, M.D.?

Below national average

NPI registry status

Active

Issued 04/22/2008

NPI 1154596096

Primary specialty

Dermatology Physician

Mid-sized

14,610 US NPIs in this specialty

Medicare Part D claims

401 45% vs specialty avg

2023 prescription claims

Specialty avg: 729

MIPS final score

75/100 8.099999999999994% pts

Above neutral band

vs 83.1 national avg

Specialty distribution in Massachusetts

How Dermatology Physician compares to other specialties among Massachusetts providers

Massachusetts providers

Dermatology Physician share within Massachusetts

1. Dermatology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Dermatology Physician share within Massachusetts

Medicare quality performance — MIPS

KATHERINE MASTERPOL, M.D.'s 2023 MIPS final score plotted against the Dermatology Physician national average

Below national average
MIPS Final Score
75/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Dermatology Physician) — 75/100 vs national avg 83.1

0%100%National avg83%75%
MIPS final score (Dermatology Physician) — 75/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

KATHERINE MASTERPOL, M.D. appears in the CMS NPPES registry as a Dermatology Physician provider holding M.D. credentials at 83 CAMBRIDGE ST STE 1A, BURLINGTON, MA, 01803, with a listed phone of (781) 272-7022. NPI 1154596096 was issued on 04/22/2008. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what MASTERPOL most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 401 prescription claims written by this provider, covering 215 Medicare beneficiaries and totaling roughly $159K in drug spend, split 10% brand-name and 90% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.

Dermatology Physician is a mid-sized specialty nationwide, with 14,610 enrolled providers across 53 states and an average of 729 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

83 CAMBRIDGE ST STE 1A
BURLINGTON, MA 01803

Provider Details

NPI 1154596096
Specialty Dermatology Physician
Credentials M.D.
Gender Female
NPI Issued 04/22/2008

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

75
Final Score
Avg: 83.1

Reporting: Group practice

Hospital and facility affiliations

Facilities where KATHERINE MASTERPOL, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

DERMPHYSICIANS OF NEW ENGLAND LLC
BURLINGTON, MA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for KATHERINE MASTERPOL, M.D.. Source: openpaymentsdata.cms.gov.

Total received

$659

Largest payer

Dermavant Sciences, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — Massachusetts BORIM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 — they are NOT specific to KATHERINE MASTERPOL, M.D.. To verify KATHERINE MASTERPOL, M.D.'s current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases

BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

KATHERINE MASTERPOL, M.D. — brand share 10.0%
Specialty average (est.)

10% brand-name claims vs 90% generic, on 401 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

401
Total Claims
$159K
Total Drug Cost
215
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
457
Total Day Supply
12,003
Brand vs Generic
10% brand / 90% generic
Brand Drug Cost
$146K
Generic Drug Cost
$12K

Patient Demographics

Average Patient Age
75.3 years
Avg HCC Risk Score
0.85
Gender Split
68% female / 32% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What KATHERINE MASTERPOL, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Triamcinolone Acetonide
85
Fluorouracil
51
Ketoconazole
49
Clobetasol Propionate
29
Metronidazole
21
Fluocinonide
20
Hydrocortisone
18
Valacyclovir
Valacyclovir Hcl
18
Prednisone
13

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Dermatology Physician Overview

How KATHERINE MASTERPOL, M.D. fits within the Dermatology Physician landscape nationally.

14,610
Dermatology Physician Providers in US
53
States with Dermatology Physician
729
Avg Claims per Provider

KATHERINE MASTERPOL, M.D.'s 401 claims are below the specialty average of 729.

Nearby Dermatology Physician Providers in Massachusetts

Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as MASTERPOL.

Compare Dermatology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is KATHERINE MASTERPOL, M.D.'s specialty?
KATHERINE MASTERPOL, M.D. specializes in Dermatology Physician and practices in BURLINGTON, Massachusetts. Credentials: M.D..
How much does KATHERINE MASTERPOL, M.D. prescribe under Medicare Part D?
In 2023, KATHERINE MASTERPOL, M.D. wrote 401 Medicare Part D claims totaling $159K in drug costs for 215 beneficiaries.
What is KATHERINE MASTERPOL, M.D.'s Medicare quality score?
KATHERINE MASTERPOL, M.D. has a CMS MIPS Final Score of 75/100. The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is KATHERINE MASTERPOL, M.D. located?
KATHERINE MASTERPOL, M.D. is located at 83 CAMBRIDGE ST STE 1A, BURLINGTON, MA, 01803. Phone: (781) 272-7022.
What is KATHERINE MASTERPOL, M.D.'s NPI number?
KATHERINE MASTERPOL, M.D.'s National Provider Identifier (NPI) is 1154596096, issued on 04/22/2008.
Does KATHERINE MASTERPOL, M.D. prescribe more brand-name or generic drugs?
KATHERINE MASTERPOL, M.D.'s prescribing is 10% brand-name and 90% generic drugs by claim count, with $146K in brand drug costs.
How many Dermatology Physician providers are there in the US?
There are 14,610 Dermatology Physician providers across 53 states in the US. The average Dermatology Physician provider writes 729 Medicare Part D claims per year.
What drugs does KATHERINE MASTERPOL, M.D. prescribe most often?
Based on 2023 Medicare Part D data, KATHERINE MASTERPOL, M.D.'s most frequently prescribed drugs include Triamcinolone Acetonide, Fluorouracil, Ketoconazole. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does KATHERINE MASTERPOL, M.D. accept Medicare?
KATHERINE MASTERPOL, M.D. appears in CMS Medicare data with 401 Part D claims and 215 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify KATHERINE MASTERPOL, M.D.'s credentials?
KATHERINE MASTERPOL, M.D.'s NPI is 1154596096 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology